Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis

Microbes and Infection

Volumn 8, Issue 12-13, 2006, Pages 2772-2776

  Anukam, Kingsley C ^a,c,d   Osazuwa, Emmanuel ^a   Osemene, Gibson I ^b   Ehigiagbe, Felix ^a   Bruce, Andrew W ^e   Reid, Gregor ^e,f  

^a UNIVERSITY OF BENIN   (Nigeria)

^b Military Base Hospital   (Nigeria)

^c Chidak Medical Diagnostic Laboratories   (Nigeria)

^d BENSON IDAHOSA UNIVERSITY   (Nigeria)

^e LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bacterial vaginosis; Intravaginal probiotics; Metronidazole

Indexed keywords

REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BLOOD CELL; CARDIOVASCULAR SYSTEM; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CRASSOSTREA GIGAS; DISEASE COURSE; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GRAM NEGATIVE INFECTION; HOST RESISTANCE; IMMUNE SYSTEM; NONHUMAN; OYSTER; PACIFIC OCEAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIBRIO; VIBRIO AESTUARIANUS;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LACTOBACILLUS; METRONIDAZOLE; MIDDLE AGED; NEURAMINIDASE; NIGERIA; ODORS; PROBIOTICS; TREATMENT OUTCOME; VAGINA; VAGINAL DISCHARGE; VAGINOSIS, BACTERIAL;

ATOPOBIUM; BACTERIA (MICROORGANISMS); GARDNERELLA; LACTOBACILLUS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MYCOPLASMA; PREVOTELLA;

EID: 33750612564     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.08.008     Document Type: Article

References (27)

1. Devillard E., Burton J.P., and Reid G. Complexity of vaginal microflora as analyzed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 13 1 (2005) 25-31
2. Hillier S.L. The complexity of microbial diversity in bacterial vaginosis. N Engl. J. Med. 353 18 (2005) 1886-1887
3. Fredricks D.N., Fiedler T.L., and Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353 18 (2005) 1899-1911
4. French J.I., McGregor J.A., and Parker R. Readily treatable reproductive tract infections and preterm birth among black women. Am. J. Obstet. Gynecol. 194 6 (2006) 1717-1726
5. Donder G.G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., and Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109 1 (2002) 34-43
6. Cauci S., Guaschino S., Driussi S., De Santo D., Lanzafame P., and Quadrifoglio F. Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J. Infect. Dis. 185 11 (2002) 1614-1620
7. Hapsari E.D., Hayashi M., and Matsuo H. Clinical characteristics of vaginal discharge in bacterial vaginosis diagnosed by Nugent's criteria. Clin. Exp. Obstet. Gynecol. 33 1 (2006) 5-9
8. Bradshaw C.S., Morton A.N., Hocking J., Garland S.M., Morris M.B., Moss L.M., Horvath L.B., Kuzevska I., and Fairley C.K. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 193 11 (2006) 1478-1486
9. Austin M.N., Beigi R.H., Meyn L.A., and Hillier S.L. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J. Clin. Microbiol. 43 9 (2005) 4492-4497
10. Sobel J.D., Ferris D., Schwebke J., Nyirjesy P., Wiesenfeld H.C., Peipert J., Soper D., Ohmit S.E., and Hillier S.L. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am. J. Obstet. Gynecol. 194 5 (2006) 1283-1289
11. Ness R.B., Kip K.E., Soper D.E., Stamm C.A., Rice P., and Richter H.E. Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Transm. Dis. 33 6 (2006) 381-385
12. Myer L., Denny L., Telerant R., Souza M., Wright Jr. T.C., and Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J. Infect. Dis. 192 8 (2005) 1372-1380
13. Cherpes T.L., Meyn L.A., Krohn M.A., and Hillier S.L. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm. Dis. 30 5 (2003) 405-410
14. Cadieux P., Burton J., Gardiner G., Braunstein I., Bruce A.W., Kang C.Y., and Reid G. Lactobacillus strains and vaginal ecology. JAMA 287 15 (2002) 1940-1941
15. Reid G., Bruce A.W., Fraser N., Heinemann C., Owen J., and Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30 1 (2001) 49-52
16. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., and Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35 2 (2003) 131-134
17. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29 2 (1991) 297-301
18. Anukam K., Osazuwa E., Ahonkhai I., Ngwu M., Osemene G., Bruce A.W., and Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 8 6 (2006) 1450-1454
19. Marrazzo J.M. Evolving issues in understanding and treating bacterial vaginosis. Expert Rev. Anti Infect. Ther. 2 6 (2004 Dec) 913-922
20. Reid G., Millsap K., and Bruce A.W. Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet. 344 8931 (1994) 1229
21. Morelli L., Zonenenschain D., Del Piano M., and Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J. Clin. Gastroenterol. 38 Suppl. 6 (2004) S107-S110
22. Burton J.P., Cadieux P.A., and Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl. Environ. Microbiol. 69 1 (2003) 97-101
23. Klebanoff M.A., Schwebke J.R., Zhang J., Nansel T.R., Yu K.F., and Andrews W.W. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet. Gynecol. 104 2 (2004) 267-272
24. Ferris M.J., Masztal A., Aldridge K.E., Fortenberry J.D., Fidel Jr. P.L., and Martin D.H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. 4 (2004) 5
25. Burton J.P., Devillard E., Cadieux P.A., Hammond J.A., and Reid G. Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J. Clin. Microbiol. 42 4 (2004) 1829-1831
26. Wiesenfeld H.C., Hillier S.L., Krohn M.A., Landers D.V., and Sweet R.L. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36 5 (2003 Mar 1) 663-668
27. Kaul R., Rowland-Jones S.L., Kimani J., Fowke K., Dong T., Kiama P., Rutherford J., Njagi E., Mwangi F., Rostron T., Onyango J., Oyugi J., MacDonald K.S., Bwayo J.J., and Plummer F.A. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol. Lett. 79 1-2 (2001 Nov 1) 3-13